Sign inGet started

Cheng Sohanya Roshan

Insider CIK 1865796 · CARM Director · KPTI SVP Sales & Commercial Ops

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KPTI Karyopharm Therapeutics In S Sale2026-05-142026-05-15324$9.50 $3.1K107,940SEC↗
KPTI Karyopharm Therapeutics In A Award2026-05-132026-05-15947— $0108,264SEC↗
KPTI Karyopharm Therapeutics In S Sale2026-03-022026-03-034,604$9.41 $43.3K107,317SEC↗
KPTI Karyopharm Therapeutics In A Award2026-01-312026-02-0332,415— $0111,921SEC↗
KPTI Karyopharm Therapeutics In A Award2025-10-152025-10-1643,650— $079,506SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-09-152025-09-16325$6.43 $2.1K35,856SEC↗
KPTI Karyopharm Therapeutics In A Award2025-09-122025-09-16945— $036,181SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-03-042025-03-063,445$6.29 $21.7K34,314SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-0410,833— $010,833SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-049,166— $09,166SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-044,583— $037,759SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-045,416— $033,176SEC↗
CARM Carisma Therapeutics Inc. A Award deriv2024-10-312024-11-0138,700— $038,700SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-09-042024-09-055,356$0.72 $3.9K404,051SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-03-012024-03-045,109$1.20 $6.1K393,509SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-02-292024-03-0421,840$1.17 $25.6K398,618SEC↗
KPTI Karyopharm Therapeutics In A Award2024-02-282024-02-29198,959— $0420,458SEC↗
KPTI Karyopharm Therapeutics In A Award2024-01-242024-01-2514,167— $0221,499SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-09-012023-09-057,415$1.33 $9.9K204,086SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-06-082023-06-121,839$2.35 $4.3K211,501SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-03-012023-03-0211,239$3.03 $34.1K210,687SEC↗
KPTI Karyopharm Therapeutics In A Award2023-02-282023-03-02100,000— $0221,926SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-08-312022-09-0145,000— $045,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-08-312022-09-0130,000— $0119,949SEC↗
KPTI Karyopharm Therapeutics In S Sale2022-06-132022-06-1466$5.35 $35391,434SEC↗
KPTI Karyopharm Therapeutics In S Sale2022-06-132022-06-141,485$5.20 $7.7K89,949SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-02-282022-03-02108,000— $0108,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-02-282022-03-0284,000— $091,500SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2021-06-302021-07-01125,000— $0125,000SEC↗
KPTI Karyopharm Therapeutics In A Award2021-06-302021-07-017,500— $07,500SEC↗